174 related articles for article (PubMed ID: 12065695)
1. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
J Pharmacol Exp Ther; 2002 Jul; 302(1):18-25. PubMed ID: 12065695
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
Kusunoki N; Yamazaki R; Kawai S
Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
J Pharm Pharmacol; 2002 Dec; 54(12):1675-9. PubMed ID: 12542898
[TBL] [Abstract][Full Text] [Related]
4. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts.
Kusunoki N; Yamazaki R; Kitasato H; Beppu M; Aoki H; Kawai S
BMC Pharmacol; 2004 Feb; 4():2. PubMed ID: 15040811
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
8. Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway.
Yamasaki S; Nakashima T; Kawakami A; Miyashita T; Ida H; Migita K; Nakata K; Eguchi K
Clin Exp Immunol; 2002 Aug; 129(2):379-84. PubMed ID: 12165097
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.
Wick M; Hurteau G; Dessev C; Chan D; Geraci MW; Winn RA; Heasley LE; Nemenoff RA
Mol Pharmacol; 2002 Nov; 62(5):1207-14. PubMed ID: 12391285
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling.
Adamson DJ; Frew D; Tatoud R; Wolf CR; Palmer CN
Mol Pharmacol; 2002 Jan; 61(1):7-12. PubMed ID: 11752200
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase.
Heneka MT; Feinstein DL; Galea E; Gleichmann M; Wüllner U; Klockgether T
J Neuroimmunol; 1999 Dec; 100(1-2):156-68. PubMed ID: 10695726
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells.
Kawai S; Nishida S; Kato M; Furumaya Y; Okamoto R; Koshino T; Mizushima Y
Eur J Pharmacol; 1998 Apr; 347(1):87-94. PubMed ID: 9650852
[TBL] [Abstract][Full Text] [Related]
15. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
Subbaramaiah K; Lin DT; Hart JC; Dannenberg AJ
J Biol Chem; 2001 Apr; 276(15):12440-8. PubMed ID: 11278336
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells.
Kusuhara H; Matsuyuki H; Matsuura M; Imayoshi T; Okumoto T; Matsui H
Eur J Pharmacol; 1998 Nov; 360(2-3):273-80. PubMed ID: 9851595
[TBL] [Abstract][Full Text] [Related]
19. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
Leung WK; Bai AH; Chan VY; Yu J; Chan MW; To KF; Wu JR; Chan KK; Fu YG; Chan FK; Sung JJ
Gut; 2004 Mar; 53(3):331-8. PubMed ID: 14960510
[TBL] [Abstract][Full Text] [Related]
20. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
